1. Home
  2. EVO vs TLRY Comparison

EVO vs TLRY Comparison

Compare EVO & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.76

Market Cap

895.8M

Sector

Health Care

ML Signal

HOLD

Logo Tilray Brands Inc.

TLRY

Tilray Brands Inc.

HOLD

Current Price

$6.82

Market Cap

919.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
TLRY
Founded
1993
N/A
Country
Germany
Canada
Employees
4766
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
895.8M
919.2M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
EVO
TLRY
Price
$2.76
$6.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$7.00
$79.25
AVG Volume (30 Days)
106.1K
2.5M
Earning Date
04-08-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.25
Revenue Next Year
$0.21
$16.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$0.36
52 Week High
$4.80
$15.70

Technical Indicators

Market Signals
Indicator
EVO
TLRY
Relative Strength Index (RSI) 52.81 50.57
Support Level $2.32 $1.12
Resistance Level $3.75 $7.08
Average True Range (ATR) 0.08 0.42
MACD 0.07 0.07
Stochastic Oscillator 85.57 81.52

Price Performance

Historical Comparison
EVO
TLRY

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About TLRY Tilray Brands Inc.

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

Share on Social Networks: